Retinal inner layer thinning detected by OCT offers a promising biomarker for monitoring multiple sclerosis progression.

A multiple sclerosis (MS) patient in the UK was the first to receive CAR T cell therapy, invented by UCL researchers, in a ...

With ads everywhere for pro- or pre-biotic foods and supplements, most people are familiar with the gut microbiome—the ...

New study shows oral microbiome imbalance and reduced salivary hypotaurine may contribute to neuroinflammation in relapsing-remitting MS.

Scientists at UCSF have uncovered evidence that multiple sclerosis silently damages the brain years before diagnosis. By ...

Researchers have traced the earliest stages of multiple sclerosis (MS), showing that the immune system begins attacking the brain up to seven years before diagnosis.

Autolus Therapeutics plc (Nasdaq: AUTL), an early commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies, announces that the ...

Now, by analyzing thousands of proteins found in the blood, scientists at UC San Francisco have created the clearest picture ...